Antineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantApoptosisAntineoplastic AgentsCaspasesApoptosis Regulatory ProteinsCisplatinCaspase 3Combined Modality TherapyDoxorubicinProto-Oncogene Proteins c-bcl-2Inhibitor of Apoptosis ProteinsCyclophosphamideCell Line, TumorTreatment OutcomeEtoposideTime FactorsDNA FragmentationBreast Neoplasmsbcl-2-Associated X ProteinCell SurvivalIn Situ Nick-End LabelingNeoadjuvant TherapySignal TransductionX-Linked Inhibitor of Apoptosis ProteinDisease-Free SurvivalLung NeoplasmsNeoplasm StagingSurvival AnalysisTumor Suppressor Protein p53Dose-Response Relationship, DrugApoptosis Inducing FactorDrug Resistance, NeoplasmTumor Cells, CulturedPrognosisCASP8 and FADD-Like Apoptosis Regulating ProteinCaspase 9Cells, CulturedPhotic StimulationCaspase InhibitorsSurvival RatePaclitaxelDrug Administration ScheduleEnzyme ActivationMitochondriaCaspase 8NeoplasmsAntineoplastic Agents, PhytogenicMethotrexateCell ProliferationFas Ligand ProteinCarboplatinVinblastinebcl-X ProteinCytochromes cFlow CytometryTaxoidsBlotting, WesternInduction ChemotherapyCell LineAntimetabolites, AntineoplasticNeoplasm Recurrence, LocalProto-Oncogene ProteinsAnnexin A5Cell CycleBleomycinDeoxycytidineIfosfamideEnzyme InhibitorsOrganoplatinum CompoundsCysteine Proteinase InhibitorsAntibiotics, AntineoplasticOvarian NeoplasmsAdenocarcinomaAmino Acid Chloromethyl KetonesPoly(ADP-ribose) PolymerasesAntineoplastic Agents, AlkylatingGeneralization, StimulusImmunohistochemistryCell DivisionReaction TimeCytarabineCarcinoma, Non-Small-Cell LungAcoustic StimulationTransfectionRNA, MessengerRNA, Small InterferingGene Expression Regulation, NeoplasticAnthracyclinesNeoplasm MetastasisMice, Inbred C57BLReactive Oxygen SpeciesNeuronsDown-RegulationDrug SynergismFollow-Up StudiesCell DeathChemotherapy, Cancer, Regional PerfusionPhosphorylationColorectal Neoplasms